NTLA · Intellia Therapeutics, Inc.

$10.92 -0.46 (-4.00%) At close · Jul 20

Market Cap

$1.53B

139.72M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Leonard	CEO	$708,000	$529,230	$2,443,920	$1,356,320	—	$26,429	$5,063,899
Edward J. Dulac III	CFO	$526,000	$270,996	$848,184	$466,609	—	$56,716	$2,168,505
David Lebwohl	Chief Medical Officer	$536,000	$234,232	$776,304	$427,061	—	$11,127	$1,984,724
James Basta	General Counsel	$494,000	$227,240	$718,800	$395,430	—	$11,127	$1,846,597
Birgit Schultes	Executive Vice President, Chief Scientific Officer	$475,000	$207,575	$675,672	$371,701	—	$10,135	$1,740,083

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Leonard	CEO	$687,000	$424,223	$10,488,027	$3,706,845	—	$24,452	$15,330,547
Edward J. Dulac III	CFO	$228,192	$303,490	$4,460,028	$1,679,022	—	$24,005	$6,694,737
David Lebwohl	Chief Medical Officer	$520,000	$201,552	$3,581,737	$1,263,021	—	$11,097	$5,577,407
Laura Sepp-Lorenzino	Chief Scientific Officer	$512,000	$184,832	$3,533,439	$1,239,029	—	$35,850	$5,505,150
James Basta	General Counsel	$479,000	$166,185	$3,159,208	$1,057,180	—	$11,097	$4,872,670
Glenn Goddard	CFO	$243,500	—	$2,873,526	$934,258	—	$395,889	$4,447,173
Michael P. Dube	Chief Accounting Officer	$364,000	$103,740	$864,415	—	—	$10,749	$1,342,904

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Leonard	CEO	$660,000	$429,000	$6,829,976	$3,707,043	—	$31,243	$11,657,262
David Lebwohl	Chief Medical Officer	$495,000	$201,960	$2,301,317	$1,249,082	—	$10,603	$4,257,962
Laura Sepp-Lorenzino	Chief Scientific Officer	$492,000	$196,800	$2,246,099	$1,219,110	—	$32,096	$4,186,105
James Basta	General Counsel	$460,000	$184,000	$2,340,966	$999,277	—	$10,548	$3,994,791
Glenn Goddard	CFO	$468,000	$159,120	$2,061,987	$1,119,165	—	$10,548	$3,818,820

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Leonard	CEO	$630,000	$401,310	$5,865,465	$3,170,309	—	$29,506	$10,096,590
Derek Hicks	Executive Vice President, Chief Business Officer	$420,000	$369,958	$2,274,851	$1,983,670	—	$33,459	$5,081,938
David Lebwohl	Chief Medical Officer	$475,300	$186,318	$1,977,001	$1,068,547	—	$9,798	$3,716,964
Laura Sepp-Lorenzino	Chief Scientific Officer	$470,000	$189,768	$1,977,001	$1,068,547	—	$10,812	$3,716,128
James Basta	General Counsel	$435,600	$170,756	$2,262,843	$746,232	—	$9,798	$3,625,229
Glenn Goddard	CFO	$450,000	$171,108	$1,820,168	$983,763	—	$9,798	$3,434,837

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
James Basta	General Counsel	$219,692	$235,200	—	$14,612,637	—	$5,430	$15,072,959
John Leonard	CEO	$600,000	$462,000	$1,811,748	$6,876,888	—	$22,924	$9,773,560
Laura Sepp-Lorenzino	Chief Scientific Officer	$441,000	$259,308	$807,940	$3,066,731	—	$4,770	$4,579,749
David Lebwohl	Chief Medical Officer	$458,300	$269,480	$735,803	$2,792,916	—	$9,060	$4,265,559
Glenn Goddard	CFO	$419,200	$234,752	$706,948	$2,683,389	—	$9,060	$4,053,349

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Leonard	CEO	$580,000	$319,000	—	$2,722,890	—	$13,786	$3,635,676
David Lebwohl	Chief Medical Officer	$298,378	$228,000	—	$1,549,720	—	$2,690	$2,078,788
Andrew D. Schiermeier	COO	$455,400	$173,052	—	$1,081,148	—	$8,928	$1,718,528
Laura Sepp-Lorenzino	Chief Scientific Officer	$420,000	$184,800	—	$1,081,148	—	$4,578	$1,690,526
Glenn Goddard	CFO	$407,000	$146,520	—	$1,001,063	—	$8,928	$1,563,511

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Laura Sepp-Lorenzino	Chief Scientific Officer	$239,487	$204,086	—	$1,318,695	—	$221	$1,762,489
Andrew D. Schiermeier	COO	$440,000	$167,200	—	$611,897	—	$8,778	$1,227,875
John Leonard	CEO	$559,200	$307,560	—	—	—	$37,026	$903,786
Glenn Goddard	CFO	$383,000	$153,200	—	—	—	$5,644	$541,844

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Leonard	CEO	$550,000	$302,500	$1,011,713	$7,818,005	—	$26,112	$9,708,330
Andrew D. Schiermeier	COO	$408,934	$182,600	$295,550	$2,028,554	—	$9,668	$2,925,306
Glenn Goddard	CFO	$67,718	$51,652	—	$1,896,825	—	$218	$2,016,413

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Leonard	CEO	$395,833	$156,170	—	$2,024,297	—	$16,574	$2,592,874

Key facts CIK 1652130 CUSIP 45826J105 13F (30d) 31 filings 31 filers Visit website Investor relations